0001209191-18-054606.txt : 20181009
0001209191-18-054606.hdr.sgml : 20181009
20181009191838
ACCESSION NUMBER: 0001209191-18-054606
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181004
FILED AS OF DATE: 20181009
DATE AS OF CHANGE: 20181009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SKIBSTED RUSSELL
CENTRAL INDEX KEY: 0001308105
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 181114681
MAIL ADDRESS:
STREET 1: 15 TRANQUILITY PLACE
CITY: LADERA RANCH
STATE: CA
ZIP: 92694
FORMER NAME:
FORMER CONFORMED NAME: Skibsted Russell
DATE OF NAME CHANGE: 20041108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOTIME INC
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE
STREET 2: SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-10-04
0
0000876343
BIOTIME INC
BTX
0001308105
SKIBSTED RUSSELL
1010 ATLANTIC AVENUE, SUITE 102
ALAMEDA
CA
94501
0
1
0
0
Chief Financial Officer
Common Shares, no par value
2018-10-04
4
M
0
11250
0.00
A
13250
D
Common Shares, no par value
2018-10-04
4
F
0
3891
2.22
D
9359
D
Restricted Stock Units
0.00
2018-10-04
4
M
0
11250
0.00
D
Common Shares
11250
33750
D
Shares earned by the Reporting Person as a result of the vesting of Restrictive Stock Units ("RSUs") granted to the Reporting Person on May 24, 2018.
Does not include RSUs payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options.
Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,250 RSUs, the grant of which was previously reported on a Form 8-K.
25% of the RSUs granted on May 24, 2018 vested on October 4, 2018, then the remaining 75% of the RSUs shall vest based on the sole determination by the Board of Directors that BioTime has achieved certain milestones, subject to the continuing employment of the Reporting Person on each vesting date. Shares of the Issuer's common stock will be delivered to the Reporting Person upon vesting.
/s/Russell Skibsted
2018-10-08